AQR Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

AQR Capital Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-49,606	Closed	-$81K	–	2366
2022 Q2	$81K	Sell	49,606 -400,304	-89%	-$831K	﹤0.01%	2110
2022 Q1	$1.32M	Buy	449,910 +139,102	+45%	+$487K	﹤0.01%	1405
2021 Q4	$1.49M	Buy	310,808 +170,603	+122%	+$1.1M	﹤0.01%	1353
2021 Q3	$1.06M	Buy	140,205 +121,723	+659%	+$779K	﹤0.01%	1505
2021 Q2	$138K	Buy	+18,482	New	+$142K	﹤0.01%	2171

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

AQR Capital Management's SURF Position: Q3 2022 in Review

AQR Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2022, closing a stake of 49,606 shares — an estimated $81K sold.

AQR Capital Management first reported a position in SURF in Q2 2021 and held it in 5 quarters. The position peaked at $1.49M in Q4 2021. 79 funds tracked by Wall St. Rank hold SURF as of Q3 2022.

AQR Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
AQR Capital Management sold 49,606 Surface Oncology, Inc. Common Stock shares in Q3 2022, an estimated $81K.
AQR Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
AQR Capital Management's Surface Oncology, Inc. Common Stock position peaked at $1.49M in Q4 2021.
79 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2022.

Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.